Pharmaceutical Nanotechnology

 Pharmaceutical Nanotechnology publishes original manuscripts, full-length/mini reviews, thematic issues, speedy technical notes and commentaries that grant insights into the synthesis, characterisation and pharmaceutical (or diagnostic) application of substances at the nanoscale. The nanoscale is defined as a measurement range of below 1 µm. Scientific findings related to micro and macro systems with performance residing within facets described at the nanoscale are additionally inside the scope of the journal. Manuscripts detailing the synthesis, exhaustive characterisation, biological evaluation, medical testing and/ or toxicological evaluation of nanomaterials are of particular pastime to the journal’s readership. Articles ought to be self contained, centred around a properly based speculation and ought to purpose to exhibit the pharmaceutical/ diagnostic implications of the nanotechnology approach. Manuscripts need to aim, anyplace possible, to demonstrate the in vivo have an effect on of any nanotechnological intervention. As reducing a fabric to the nanoscale is capable of essentially altering the material’s properties, the journal’s readership is especially involved in new characterisation strategies and the advanced properties that originate from this measurement reduction.

    Related Conference of Pharmaceutical Nanotechnology

    May 30-31, 2024

    9th Annual Conference and Expo on Biomaterials

    Vienna, Austria

    Pharmaceutical Nanotechnology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in